SEC Filings
TransMedics Revenue Climbs 41% To $203 Million — But Net Profit Falls
The organ-transplant technology company raised its annual sales outlook as liver and heart volumes grew and logistics added revenue.
TMDX
TransMedics Group (TMDX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Markets
TransMedics Stock Soars 17.95% After Raising Its Annual Revenue Outlook — Adding $429 Million
Service revenue grew 60% from a year earlier, while adjusted earnings per share declined.
Earnings
TransMedics CEO Says October Flights Were Down, Won't 'Give Up On The Quarter'
Waleed Hassanein conceded a soft October after raising 2026 revenue guidance to $764 million to $774 million.